Sam Chan
Senior Scientist at Architect Therapeutics | San Diego, California, United States
Sam Chan’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Senior Scientist at Architect Therapeutics in March 2024 - Present
Scientist II at Architect Therapeutics in July 2023 - February 2024
Postdoctoral Research Fellow at Scripps Research in December 2020 - July 2023
Postdoctoral Research Associate at University of Oxford in August 2019 - May 2020
Undergraduate Research Assistant at The University of Hong Kong in January 2014 - January 2015
The University of Hong Kong, Bachelor of Science - BS, Chemistry, First-class Honours, August 2026
University of Oxford, Doctor of Philosophy - DPhil, Organic Chemistry, August 2026
Vice Chairman of The Board of Trustees at Salk Institute for Biological Studies
Chairman of the BOD and Co-Founder at Architect Therapeutics
(Aug 2023 – Present)
Co-founder/CEO Architect Therapeutics
ElevAAte is a non-profit focused on increasing East Asian representation at senior leadership levels across the biotech/pharma industry
Redmile Group
Board Director at Abcuro, Inc
(Jan 2024 – Present)
Vice President, Architect Therapeutics
Precision chemical editing platform for drugging tough targets. Incubated and launched company out of ARCH. Foundational science from Yu Lab and Cravatt Lab.
Chief Financial Officer, Board Member and Strategic Advisor
Chief Financial Officer at Architect Therapeutics
(Mar 2023 – Present)
CSO at Architect Therapeutics
Chief Scientific Officer at Architect Therapeutics
(Oct 2025 – Present)
